Reply
Brivaracetram is in our R&D pipeline, in order to be developed and launched to the market in the coming years. Our estimated deadlines are the following:
-R&D development: Q1-Q4 2019
-Validation batches: Q1 2020
-Stability tests (6 months): Q2-Q3 2020
-Full DMF Availability: Q3 2020
If you need further information do not hesitate to contact us:
Sergi Collazos – Director Business Development
http://www.lebsa.com">www.lebsa.com
scollazos@lebsa.com
+34 933770051
veyongvet9@vip.163.com
Dear friend,
Very glad to introduce our Veterinary APIs to you!
This is Chris Geng from Hebei Veyong Animal Pharmaceutical Co., Ltd located in China.
Our company is a manufacturer and exporter of VETERINARY MEDICINE, including veterinary API and formulations. Also we have some agrochemicals.
So please contact us freely if you are interested in our products.
Wish you have a good business! Thanks and best regards!
Chirs Geng
Email: veyongvet9@vip.163.com /veyongvet@outlook.com
Tel: +86 0311 86065103
QQ: 202414843
Web: www.veyongvet.com
